Legend Biotech Corporation

Capital Raising · Americas

Twist Bioscience completed a US$300 million follow-on equity offering at US$96/share, upsized from an initially filed US$250 million raise. Concurrent with Q3 2026 results showing US$118.38M revenue and US$35.05M loss, company raised FY2026 guidance to US$456-457M.

Capital Raising · Americas

Ratio Therapeutics closed a Series C funding round of $70M for radiopharmaceutical trials, led by existing investors Duquesne Family Office and Bristol Myers Squibb, with new investor participation.

Capital Raising · Americas

BridgeBio secured funding to support drug launch; United Airlines made an investment into the cell therapy space

Capital Raising · Americas

Schedule 13G filing indicates potential significant ownership change or investment activity

Ma Activity · Americas

Amgen is terminating its partnership with TScan Therapeutics, a T cell therapy company based in Waltham, MA.

Ma Activity · Americas

BioMarin agreed to acquire Alesta Therapeutics for up to $490 million ($275M upfront + $215M in milestones) to add ALE1, a clinical-stage oral therapy for hypophosphatasia (rare genetic bone disease), to its rare disease pipeline.